Business · 09/01/2002
FDA Announces Opportunity for Hearing on Proposal to Revoke Biologics Licenses of Four Plasma Companies
The FDA is seeking public input on a proposal to revoke the licenses of Beauregard Plasma, Jackson Plasma, Baton Rouge Plasma, and Claiborne Plasma, which manufacture Source Plasma, due to lack of access for inspections and discontinued manufacturing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →